|
|
Article: Drug Terminates Paroxysmal Supraventricular Tachycardia With Fewer Side Effects.
- Article from:
- Biotech Week
- Article date:
- December 12, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 DEC 12 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., announced the presentation of results from a retrospective analysis comparing the proarrhythmic effects of adenosine and CVT-510, a selective A1 adenosine receptor agonist.
Data from this analysis indicated that after termination of paroxysmal supraventricular tachycardia (PSVT), a type of atrial arrhythmia, with either adenosine or CVT-510, the use of CVT-510 was associated with fewer abnormal ventricular beats and fewer postarrhythmia pauses, or skipped heartbeats.
These data were presented November 12, 2001, at the 2001 Scientific Sessions of the American Heart Association held in ...